Osteoporosis: A Silent Disease with Complex Genetic Contribution

a.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol 4717647745, Iran
b.
Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences & Health Services, Tehran 1985717443, Iran

More Information

Corresponding author: E-mail address: halehakhavan@yahoo.com (Haleh Akhavan-Niaki)

摘要

- /
- /
- /
Abstract: Osteoporosis is the most common multifactorial metabolic bone disorder worldwide with a strong genetic component. In this review, the evidence for a genetic contribution to osteoporosis and related phenotypes is summarized alongside with methods used to identify osteoporosis susceptibility genes. The key biological pathways involved in the skeleton and bone development are discussed with a particular focus on master genes clustered in these pathways and their mode of action. Furthermore, the most studied single nucleotide polymorphisms (SNPs) analyzed for their importance as genetic markers of the disease are presented. New data generated by next-generation sequencing in conjunction with extensive meta-analyses should contribute to a better understanding of the genetic basis of osteoporosis and related phenotype variability. These data could be ultimately used for identifying at-risk patients for disease prevention by both controlling environmental factors and providing possible therapeutic targets.
- Osteoporosis /
- Bone mineral density /
- Regulatory pathways /
- Single nucleotide polymorphisms

HTML全文

参考文献(111)

[1]	Albagha, O.M., Wani, S.E., Visconti, M.R. et al. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone Nat. Genet., 43 (2011),pp. 685-689
[2]	Angers, S., Moon, R.T. Proximal events in Wnt signal transduction Nat. Rev. Mol. Cell Biol., 10 (2009),pp. 468-477
[3]	Ardawi, M.S.M., Maimany, A.A., Bahksh, T.M. et al. Bone mineral density of the spine and femur in healthy Saudis Osteoporos. Int., 16 (2005),pp. 43-55
[4]	Arnold, M.A., Kim, Y., Czubryt, M.P. et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development Dev. Cell, 12 (2007),pp. 377-389
[5]	Ashford, R.U., Luchetti, M., McCloskey, E.V. et al. Studies of bone density, quantitative ultrasound, and vertebral fractures in relation to collagen type I alpha 1 alleles in elderly women Calcif. Tissue Int., 68 (2001),pp. 348-351
[6]	Aspray, T.J. Fragility fracture: recent developments in risk assessment Ther. Adv. Musculoskelet. Dis., 7 (2015),pp. 17-25
[7]	Balemans, W., Ebeling, M., Patel, N. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum. Mol. Genet., 10 (2001),pp. 537-543
[8]	Banziger, C., Soldini, D., Schutt, C. et al. Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells Cell, 125 (2006),pp. 509-522
[9]	Batra, G.S., Hainey, L., Freemont, A.J. et al. Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women J. Pathol., 200 (2003),pp. 65-73
[10]	Berg, J.P., Lehmann, E.H., Stakkestad, J.A. et al. Eur. J. Endocrinol., 143 (2000),pp. 261-265
[11]	Bezerra, M.C., Carvalho, J.F., Prokopowitsch, A.S. et al. RANK, RANKL and osteoprotegerin in arthritic bone loss Braz. J. Med. Biol. Res., 38 (2005),pp. 161-170
[12]	Bjørnerem, A., Bui, M., Wang, X. et al. Genetic and environmental variances of bone microarchitecture and bone remodeling markers: a twin study J. Bone Miner. Res., 30 (2015),pp. 516-524
[13]	Blake, J., Riddell, A., Theiss, S. et al. Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation PLoS One, 9 (2014),p. e90894
[14]	Bonewald, L.F., Mundy, G.R. Role of transforming growth factor-beta in bone remodeling Clin. Orthop. Relat. Res., 250 (1990),pp. 261-276
[15]	Botzenhart, E.M., Green, A., Ilyina, H. et al. Hum. Mutat., 26 (2005),p. 282
[16]	Boudin, E., Steenackers, E., de Freitas, F. et al. Bone, 53 (2013),pp. 414-420
[17]	Butler, J.S., Murray, D.W., Hurson, C.J. et al. The role of DKK1 in bone mass regulation: correlating serum DKK1 expression with bone mineral density J. Orthop. Res., 29 (2011),pp. 414-418
[18]	Cauley, J.A., Seeley, D.G., Ensrud, K. et al.
[19]	Cho, Y.S., Go, M.J., Kim, Y.J. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits Nat. Genet., 41 (2009),pp. 527-534
[20]	Cummings, S.R., Nevitt, M.C., Browner, W.S. et al.
[21]	Deng, H.W., Chen, W.M., Recker, S. et al. Genetic determination of Colles' fracture and differential bone mass in women with and without Colles' fracture J. Bone Miner. Res., 15 (2000),pp. 1243-1252
[22]	Dougherty, G., Al-Marzouk, N. Bone density measured by dual-energy X-ray absorptiometry in healthy Kuwaiti women Calcif. Tissue Int., 68 (2001),pp. 225-229
[23]	Duncan, E.L., Brown, M.A. Clinical review 2: genetic determinants of bone density and fracture risk–state of the art and future directions J. Clin. Endocrinol. Metab., 95 (2010),pp. 2576-2587
[24]	El-Desouki, M.I. Osteoporosis in postmenopausal Saudi women using dual X-ray bone densitometry Saudi Med. J., 24 (2003),pp. 953-956
[25]	El-Hajj Fuleihan, G., Baddoura, R., Awada, H. et al. Low peak bone mineral density in healthy Lebanese subjects Bone, 31 (2002),pp. 520-528
[26]	Estrada, K., Styrkarsdottir, U., Evangelou, E. et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture Nat. Genet., 44 (2012),pp. 491-501
[27]	Fang, Y., van Meurs, J.B., Arp, P. et al. Vitamin D binding protein genotype and osteoporosis Calcif. Tissue Int., 85 (2009),pp. 85-93
[28]	Fini, M., Carpi, A., Borsari, V. et al. Bone remodeling, humoral networks and smart biomaterial technology for osteoporosis Front. Biosci. (Schol Ed), 2 (2010),pp. 468-482
[29]	Foster, J.W., Dominguez-Steglich, M.A., Guioli, S. et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene Nature, 372 (1994),pp. 525-530
[30]	Frishberg, Y., Topaz, O., Bergman, R. et al. J. Mol. Med. (Berl), 83 (2005),pp. 33-38
[31]	Geiser, A.G., Zeng, Q.Q., Sato, M. et al. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene Bone, 23 (1998),pp. 87-93
[32]	Gennari, L., Merlotti, D., Martini, G. et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men J. Clin. Endocrinol. Metab., 88 (2003),pp. 5327-5333
[33]	Geoffroy, V., Kneissel, M., Fournier, B. et al. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage Mol. Cell. Biol., 22 (2002),pp. 6222-6233
[34]	Giuliani, N., Girasole, G., Vescovi, P.P. et al. Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures Alcohol Clin. Exp. Res., 23 (1999),pp. 381-385
[35]	Giustina, A., Mazziotti, G., Canalis, E. Growth hormone, insulin-like growth factors, and the skeleton Endocr. Rev., 29 (2008),pp. 535-559
[36]	, Bialek, P., Ahn, J.D., Starbuck, M. et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Dev. Cell, 8 (2005),pp. 751-764
[37]	Gong, Y., Vikkula, M., Boon, L. et al. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13 Am. J. Hum. Genet., 59 (1996),pp. 146-151
[38]	Gowen, L.C., Petersen, D.N., Mansolf, A.L. et al. J. Biol. Chem., 278 (2003),pp. 1998-2007
[39]	Grant, S.F., Reid, D.M., Blake, G. et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene Nat. Genet., 14 (1996),pp. 203-205
[40]	Gu, X., Shin, B.H., Akbarali, Y. et al. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6 J. Biol. Chem., 276 (2001),pp. 9421-9436
[41]	Gueguen, R., Jouanny, P., Guillemin, F. et al. Segregation analysis and variance-components analysis of bone-mineral density in healthy families Alcohol Clin. Exp. Res., 10 (1995),pp. 2017-2022
[42]	Guo, Y., Tan, L.J., Lei, S.F. et al. PLoS Genet., 6 (2010),p. e1000806
[43]	Hak, A.E., Witteman, J.C., Hugens, W. et al. The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study Atherosclerosis, 175 (2004),pp. 169-176
[44]	Hammoudeh, M., Al-Khayarin, M., Zirie, M. et al. Bone density measured by dual energy X-ray absorptiometry in Qatari women Maturitas, 52 (2005),pp. 319-327
[45]	Hardy, J., Singleton, A. Genomewide association studies and human disease N. Engl. J. Med., 360 (2009),pp. 1759-1768
[46]	Hock, J.M., Gera, I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone J. Bone Miner. Res., 7 (1992),pp. 65-72
[47]	Holmen, S.L., Zylstra, C.R., Mukherjee, A. et al. Essential role of beta-catenin in postnatal bone acquisition J. Biol. Chem., 280 (2005),pp. 21162-21168
[48]	Hsu, Y.H., Kiel, D.P. Genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed J. Clin. Endocrinol. Metab., 97 (2012),pp. e1958-e1977
[49]	Hsu, Y.H., Zillikens, M.C., Wilson, S.G. et al. An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility loci for osteoporosis-related traits PLoS Genet., 6 (2010),p. e1000977
[50]	Ioannidis, J.P., Ng, M.Y., Sham, P.C. et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass J. Bone Miner. Res., 22 (2007),pp. 173-183
[51]	Janssens, K., Gershoni-Baruch, R., Guanabens, N. et al. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease Nat. Genet., 26 (2000),pp. 273-275
[52]	Johansson, A.G., Burman, P., Westermark, K. et al. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I J. Intern. Med., 232 (1992),pp. 447-452
[53]	Judson, R.N., Wackerhage, H., Hughes, A. et al. The functional ACTN3 577X variant increases the risk of falling in older females: results from two large independent cohort studies J. Gerontol. A Biol. Sci. Med. Sci., 66 (2011),pp. 130-135
[54]	Kamel, H.K. Postmenopausal osteoporosis: etiology, current diagnostic strategies, and nonprescription interventions J. Manag. Care Pharm., 12 (2006),pp. S4-S9
[55]	Kanis, J.A., , Christiansen, C., Johnston, C.C. et al. The diagnosis of osteoporosis J. Bone Miner. Res., 9 (1994),pp. 1137-1141
[56]	Kanis, J.A., Reginster, J.Y. European guidance for the diagnosis and management of osteoporosis in postmenopausal women–what is the current message for clinical practice? Pol. Arch. Med. Wewn., 118 (2008),pp. 538-540
[57]	Karch, C.M., Goate, A.M. Alzheimer's disease risk genes and mechanisms of disease pathogenesis Biol. Psychiatry, 77 (2015),pp. 43-51
[58]	Khosla, S., , Riggs, B.L. Clinical review 144: estrogen and the male skeleton J. Clin. Endocrinol. Metab., 87 (2002),pp. 1443-1450
[59]	Kiel, D.P., Demissie, S., Dupuis, J. et al. Genome-wide association with bone mass and geometry in the Framingham Heart Study BMC Med. Genet., 8 (2007),p. S14
[60]	Kochupillai, N. The physiology of vitamin D: current concepts Indian J. Med. Res., 127 (2008),pp. 256-262
[61]	Koller, D.L., Ichikawa, S., Lai, D. et al. Genome-wide association study of bone mineral density in premenopausal European-American women and replication in African-American women J. Clin. Endocrinol. Metab., 95 (2010),pp. 1802-1809
[62]	Komori, T., Yagi, H., Nomura, S. et al. Cell, 89 (1997),pp. 755-764
[63]	Krall, E.A., Dawsonhughes, B. Heritable and life-style determinants of bone-mineral density J. Bone Miner. Res., 8 (1993),pp. 1-9
[64]	Kumar, J., Swanberg, M., McGuigan, F. et al. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways Bone, 49 (2011),pp. 343-348
[65]	Kwan Tat, S., Padrines, M., Theoleyre, S. et al. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology Cytokine Growth Factor Rev., 15 (2004),pp. 49-60
[66]	Lau, E.M., Choy, D.T., Li, M. et al. Calcif. Tissue Int., 75 (2004),pp. 133-137
[67]	Leupin, O., Kramer, I., Collette, N.M. et al. Control of the SOST bone enhancer by PTH using MEF2 transcription factors J. Bone Miner. Res., 22 (2007),pp. 1957-1967
[68]	Li, J., Sarosi, I., Cattley, R.C. et al. Bone, 39 (2006),pp. 754-766
[69]	Li, W.F., Hou, S.X., Yu, B. et al. Genetics of osteoporosis: accelerating pace in gene identification and validation Hum. Genet., 127 (2010),pp. 249-285
[70]	Liu, C.T., Karasik, D., Zhou, Y. et al. Heritability of prevalent vertebral fracture and volumetric bone mineral density and geometry at the lumbar spine in three generations of the Framingham study J. Bone Miner. Res., 27 (2012),pp. 954-958
[71]	Ljunghall, S., Johansson, A.G., Burman, P. et al. Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis J. Intern. Med., 232 (1992),pp. 59-64
[72]	Maalouf, G., Salem, S., Sandid, M. et al. Bone mineral density of the Lebanese reference population Osteoporos. Int., 11 (2000),pp. 756-764
[73]	Mann, V., Hobson, E.E., Li, B. et al. J. Clin. Invest., 107 (2001),pp. 899-907
[74]	Manolio, T.A., Collins, F.S., Cox, N.J. et al. Finding the missing heritability of complex diseases Nature, 461 (2009),pp. 747-753
[75]	McLean, R.R. Proinflammatory cytokines and osteoporosis Curr. Osteoporos. Rep., 7 (2009),pp. 134-139
[76]	Miclea, R.L., Karperien, M., Langers, A.M. et al. J. Bone Miner. Res., 25 (2010),pp. 2624-2632
[77]	Morvan, F., Boulukos, K., Clement-Lacroix, P. et al. J. Bone Miner. Res., 21 (2006),pp. 934-945
[78]	Murray, R.E., McGuigan, F., Grant, S.F. et al. Polymorphisms of the interleukin-6 gene are associated with bone mineral density Bone, 21 (1997),pp. 89-92
[79]	Nakajima, T., Ota, N., Shirai, Y. et al. Calcif. Tissue Int., 65 (1999),pp. 352-353
[80]	Neer, R.M., Arnaud, C.D., Zanchetta, J.R. et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N. Engl. J. Med., 344 (2001),pp. 1434-1441
[81]	Nevitt, M.C., Ettinger, B., Black, D.M. et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study Ann. Intern. Med., 128 (1998),pp. 793-800
[82]	NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy Osteoporosis prevention, diagnosis, and therapy JAMA, 285 (2001),pp. 785-795
[83]	Otto, F., Thornell, A.P., Crompton, T. et al. Cell, 89 (1997),pp. 765-771
[84]	Parhami, F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot. Essent. Fatty Acids, 68 (2003),pp. 373-378
[85]	Peter, I., Crosier, M.D., Yoshida, M. et al. Osteoporos. Int., 22 (2011),pp. 1199-1209
[86]	Ralston, S.H., de Crombrugghe, B. Genetic regulation of bone mass and susceptibility to osteoporosis Genes Dev., 20 (2006),pp. 2492-2506
[87]	Ralston, S.H., Uitterlinden, A.G. Genetics of osteoporosis Endocr. Rev., 31 (2010),pp. 629-662
[88]	Richards, J.B., Rivadeneira, F., Inouye, M. et al. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study Lancet, 371 (2008),pp. 1505-1512
[89]	Richards, J.B., Kavvoura, F.K., Rivadeneira, F. et al. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture Ann. Intern. Med., 151 (2009),pp. 528-537
[90]	Rivadeneira, F., Styrkarsdottir, U., Estrada, K. et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies Nat. Genet., 41 (2009),pp. 1199-1206
[91]	Simonet, W.S., Lacey, D.L., Dunstan, C.R. et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell, 89 (1997),pp. 309-319
[92]	Sivas, F., Alemdaroglu, E., Elverici, E. et al. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women Rheumatol. Int., 29 (2009),pp. 885-890
[93]	Smits, P., Li, P., Mandel, J. et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation Dev. Cell, 1 (2001),pp. 277-290
[94]	Snieder, H., MacGregor, A.J., Spector, T.D. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause J. Clin. Endocrinol. Metab., 83 (1998),pp. 1875-1880
[95]	Solomon, D.H., Avorn, J., Canning, C.F. et al. Lipid levels and bone mineral density Am. J. Med., 118 (2005),p. 1414
[96]	Soroko, S.B., Barrettconnor, E., Edelstein, S.L. et al. Family history of osteoporosis and bone-mineral density at the axial skeleton – the Rancho-Bernardo Study J. Bone Miner. Res., 9 (1994),pp. 761-769
[97]	Stone, M.A., Osei-Bordom, D.C., Inman, R.D. et al. Heritability of spinal curvature and its relationship to disc degeneration and bone mineral density in female adult twins Eur. Spine J., 24 (2015),pp. 2387-2394
[98]	Styrkarsdottir, U., Halldorsson, B.V., Gretarsdottir, S. et al. Multiple genetic loci for bone mineral density and fractures N. Engl. J. Med., 358 (2008),pp. 2355-2365
[99]	Styrkarsdottir, U., Halldorsson, B.V., Gretarsdottir, S. et al. New sequence variants associated with bone mineral density Nat. Genet., 41 (2009),pp. 15-17
[100]	Torgerson, D.J., Campbell, M.K., Thomas, R.E. et al. Prediction of perimenopausal fractures by bone mineral density and other risk factors J. Bone Miner. Res., 11 (1996),pp. 293-297
[101]	Uitterlinden, A.G., van Meurs, J.B., Rivadeneira, F. et al. Identifying genetic risk factors for osteoporosis J. Musculoskelet. Neuronal Interact., 6 (2006),pp. 16-26
[102]	Urano, T., Shiraki, M., Usui, T. et al. J. Bone Miner. Metab., 27 (2009),pp. 562-566
[103]	Utennam, D., Tungtrongchitr, A., Phonrat, B. et al. Association of T869C gene polymorphism of transforming growth factor-beta1 with low protein levels and anthropometric indices in osteopenia/osteoporosis postmenopausal Thai women Genet. Mol. Res., 11 (2012),pp. 87-99
[104]	Vallet, M., Soares, D.C., Wani, S. et al. Targeted sequencing of the Paget's disease associated 14q32 locus identifies several missense coding variants in RIN3 that predispose to Paget's disease of bone Hum. Mol. Genet., 24 (2015),pp. 3286-3295
[105]	Vodopiutz, J., Zoller, H., Fenwick, A.L. et al. J. Pediatr., 162 (2013),pp. 612-617
[106]	Wang, Q., Wei, X.C., Zhu, T.H. et al. J. Biol. Chem., 282 (2007),pp. 10742-10748
[107]	Wilson, S.G., Reed, P.W., Andrew, T. et al. A genome-screen of a large twin cohort reveals linkage for quantitative ultrasound of the calcaneus to 2q33-37 and 4q12-21 J. Bone Miner. Res., 19 (2004),pp. 270-277
[108]	Xiao, S.M., Kung, A.W., Sham, P.C. et al. Genetic analysis of recently identified osteoporosis susceptibility genes in southern Chinese J. Clin. Endocrinol. Metab., 98 (2013),pp. e1827-e1834
[109]	Xiong, D.H., Shen, H., Xiao, P. et al. Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis J. Bone Miner. Res., 21 (2006),pp. 424-437
[110]	Yanase, T., Simpson, E.R., Waterman, M.R. 17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition Endocr. Rev., 12 (1991),pp. 91-108
[111]	Zheng, H.F., Spector, T.D., Richards, J.B. Insights into the genetics of osteoporosis from recent genome-wide association studies Expert Rev. Mol. Med., 13 (2011),p. e28